Fusion Pharm, Inc. reported earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of $305,000. The company had a net loss of $47,795 for the quarter, primarily attributable to the start up nature of its business and the scaling of the company's operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2014 | Fusion Pharm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2014 | CI |
2014 | FusionPharm to Open Seattle Sales Center | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.26K | |
-.--% | 339M | |
-39.55% | 331M | |
+47.33% | 290M | |
+32.99% | 274M | |
+51.74% | 198M | |
+145.30% | 140M | |
+53.54% | 139M | |
-28.57% | 122M | |
+19.23% | 104M |
- Stock Market
- Equities
- FSPM Stock
- News FusionPharm, Inc.
- Fusion Pharm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2014